The health-care industry seemed to have been among the biggest winners in the $1.1 trillion Omnibus appropriations act for fiscal 2016 signed Dec. 18 by President Barack Obama. But Fitch Ratings has a different take on that.

Martin Shkreli, the former hedge-fund manager turned pharmaceutical CEO who was arrested this month, has been described as a sociopath and worse. In reality, he’s a brasher and larger version of what others in finance and in corporate suites do all the time.

The pharmaceutical industry is preparing to spend tens of millions of dollars to convince California voters to reject what would be the strictest state law in the nation to cap drug prices.

The more drugs people take and the sicker they are, the more likely they are to experience problems paying for prescription medicines–or to forgo them altogether because of cost.

Two years after the Affordable Care Act began requiring most Americans to have health insurance, 10.5 million who are eligible to buy coverage through the law’s new insurance exchanges were still uninsured this fall, according to the Obama administration.

A more than $1 billion hole in California's Medi-Cal budget is likely to be a high-priority agenda item for California lawmakers this year, the AP/Sacramento Bee reports.